Charl Verwey to Respiratory Syncytial Virus, Human
This is a "connection" page, showing publications Charl Verwey has written about Respiratory Syncytial Virus, Human.
Connection Strength
2,241
-
Pulmonary sequelae in 2-year-old children after hospitalisation for respiratory syncytial virus lower respiratory tract infection during infancy: an observational study. BMJ Open Respir Res. 2023 05; 10(1).
Score: 0,737
-
Review and Update of Active and Passive Immunization Against Respiratory Syncytial Virus. BioDrugs. 2023 May; 37(3):295-309.
Score: 0,736
-
Impact of Respiratory Syncytial Virus and Severe Acute Respiratory Syndrome Coronavirus 2 Coinfection on Clinical Severity and Outcomes Among Children Hospitalized With Lower Respiratory Tract Infections in Soweto, South Africa. Pediatr Infect Dis J. 2025 Feb 01; 44(2):107-111.
Score: 0,203
-
The genomic evolutionary dynamics and global circulation patterns of respiratory syncytial virus. Nat Commun. 2024 Apr 10; 15(1):3083.
Score: 0,197
-
All-cause and pathogen-specific lower respiratory tract infection hospital admissions in children younger than 5 years during the COVID-19 pandemic (2020-22) compared with the pre-pandemic period (2015-19) in South Africa: an observational study. Lancet Infect Dis. 2023 09; 23(9):1031-1041.
Score: 0,184
-
Nirsevimab binding-site conservation in respiratory syncytial virus fusion glycoprotein worldwide between 1956 and 2021: an analysis of observational study sequencing data. Lancet Infect Dis. 2023 07; 23(7):856-866.
Score: 0,183